why choose us

First received: November 10, 2023

Clinical Trial: Phenomenological Explorations of the Esketamine-Induced Transient Dissociative State

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Depressive Disorder

Study Type: INTERVENTIONAL


Official Title: Phenomenological Explorations of the Esketamine-Induced Transient Dissociative State

Brief Summary: Ketamine is an anaesthetic used in low doses to treat depressive disorders.A related molecule, Esketamine, has recently been launched on the market for the treatment of resistant depression.One of the side effects of ketamine, like Esketamine, is induction of transient dissociative state.Dissociation has been described as disruption in continuity of conscious thought and emotion, cognitive processes disorganisation and an alteration in self-perception and environment perception.A study of healthy volunteers…

Read more